PLRX Q1 2025 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PLRXPliant Therapeutics, Inc.

$85M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$59M

Net Income

-$56M

EPS (Diluted)

$-0.92

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$49M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$345M

Total Liabilities

$88M

Stockholders' Equity

$257M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$513,000	+100.0%
Operating Income	-$59M	-$52M	-12.5%
Net Income	-$56M	-$47M	-19.6%